ZYXORIN

Zyxorin is an anti-inflammatory or immunomodulatory compound used experimentally. It may inhibit proinflammatory cytokines. Side effects can include nausea, dizziness, headache, allergic reactions, or mild liver enzyme elevations. Only GMP materials will be supplied, logistics all according to GDP.

SKU: 7cfe57fef327 Category: Tag:

Product Description


Mechanism of Action

ZYXORIN demonstrates a multiaxis biochemical interference profile spanning catalyticdomain perturbation, mitochondrialnetwork recalibration, ionflux redistribution, membranepotential modulation, cytoskeletal remodelling, redoxequilibrium restructuring and transcriptionfactor pathway reprogramming. Its molecular architecture supports docking to catalytic residues, allosteric control nodes, transmembrane helices, nucleotidebinding sites, redoxbuffer matrices and polymeric scaffold proteins. This enables systemwide modulation across metabolic, structural, genomic and electrophysiological regulatory layers.

Mechanistic effects include redistribution of phosphorylation flux across ERK/MAPK/JNK/p38 signalling axes, modulation of PI3KAKT survivalpathway geometry, reconfiguration of Gprotein coupling logic, reshaping of Ca²⁺ microdomain behaviour, alteration of IP/DAG cascade topology and amplitude recalibration within the cAMPPKA axis. Mitochondrial influences include ETCcomplex rebalancing, ATP/ADP flux modelling shifts, ROSthreshold displacement, mitochondrialmembrane potential polarity adjustments and crossorganelle stresssignal propagation between ER and mitochondrial systems.

Advanced

  • Kinomelevel catalyticcascade interference mapping
  • Highprecision ligand docking & conformationaltransition simulations
  • UPR/ERstress, mitophagy & autophagicflux network modelling
  • Multiomics integration (RNAseq, proteomics, metabolomics, phosphoproteomics)
  • Cytoskeletal mechanics, forcedistribution profiling & polymer turnover
  • Cellfate modelling across apoptosis, necroptosis, ferroptosis & parthanatos
  • SAR/QSAR optimisation with machinelearningbased compound performance modelling

Toxicodynamics & Hazard Spectrum

  • Rapid ROS accumulation & antioxidantbuffer collapse
  • Mitochondrial fragmentation or ETC suppression
  • Severe Na⁺/K⁺/Ca²⁺ ionflux destabilisation
  • Cytoskeletal depolymerisation & membrane-integrity failure
  • Hyperactivation of NF-κB, STAT & IRF inflammatory regulators
  • Induction of multiaxis programmed-cell-death pathways
  • Epigenetic drift including methylation/acetylation instability

For expert laboratory research only not intended for biological use.

Only GMP materials will be supplied, logistics all according to GDP.

Datasheet


Molecular Formula

C16H15F3O

Molecular Weight

280.28 g/mol

CAS Number

56430-99-0

Storage Condition

Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light.

Solubility

Solubility depends on solvent and conditions (e.g., pH). Please contact us for solvent-specific guidance.

Purity

Purity information is available upon request (COA).

Synonym

FLUMECINOL; Zixoryn; 56430-99-0; Flumecinolum; JB0YA8LDOW

IUPAC/Chemical Name

1-phenyl-1-[3-(trifluoromethyl)phenyl]propan-1-ol

InChl Key

DVASNQYQOZHAJN-UHFFFAOYSA-N

InChl Code

InChI=1S/C16H15F3O/c1-2-15(20,12-7-4-3-5-8-12)13-9-6-10-14(11-13)16(17,18)19/h3-11,20H,2H2,1H3

References

https://pubchem.ncbi.nlm.nih.gov/compound/41870;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download